In the original article, there were mistakes in [Figure 1J](#F1){ref-type="fig"} and [Figure 6E](#F2){ref-type="fig"} as published. [Figure 1J](#F1){ref-type="fig"} (representative FACS plot of CD4^+^IFN-γ^+^ cells) was mistakenly duplicated from [Figure 1I](#F1){ref-type="fig"} (representative FACS plot of CD4^+^IL-17^+^ cells), and the tubulin band of [Figure 6E](#F2){ref-type="fig"} was inadvertently covered by the band of that in [Figure 6C](#F2){ref-type="fig"}. The corrected [Figure 1](#F1){ref-type="fig"} and [Figure 6](#F2){ref-type="fig"} appear below.

![Attenuated dextran sulfate sodium (DSS)-induced colitis in miR-155^−/−^ mice is dependent on commensal bacteria. WT or miR-155^−/−^ mice were given 3% DSS in drinking water for 5 days, followed by regular drinking water for 6 days. **(A--E)** Weight change **(A)**, Kaplan--Meier plot of survival rate **(B)**, stool blood **(C)**, representative gross colon appearance \[**(D)** left\] and colon length \[**(D)** right\], and representative H&E-stained colon cross-sections \[**(E)** left, original magnification, 200× or 400×\] and semi-quantitative histopathology score \[**(E)** right\]. **(F)** WT and miR-155^−/−^ mice were treated with broad-spectrum antibiotics cocktail (ABX) for 4 weeks and then given 3% DSS, the body weight change (left) and DAI (right) were monitored daily. Ns vs WT control **(G,H)**. The LPMCs were isolated from colon tissues of DSS-treated WT (*n* = 12) and miR-155^−/−^ (*n* = 15) mice, then the total number of LPMCs (CD45^+^) **(G)**, T cells (CD4^+^ and CD8^+^), DCs (CD11c^+^CD11b^−^) and macrophages (CD11b^+^CD11c^−/low^) **(H)** were counted by flow cytometry. **(I,J)** Representative FACS showing CD4^+^IL-17^+^ cells **(I)** and CD4^+^IFN-γ^+^ cells **(J)** in isolated LPMCs of DSS-treated WT (*n* = 12) and miR-155^−/−^ (*n* = 15) mice. \**P* \< 0.05, \*\**P* \< 0.01 vs WT control \[Student\'s *t*-test in **(A,D,E,G,H)** and Kaplan--Meier analysis in **(B,C)**\]. ns vs WT control. Data are representative of three independent experiments (mean and SD in A-D); *n* = 12--15 mice per group in **(A--F)** and *n* = 5--6 mice per group in **(G)**. ns, not significant. WT, wild-type.](fimmu-10-03153-g0001){#F1}

![C/EBPβ and SOCS1 are key functional targets in intestinal M2 polarization. **(A)** BMDMs isolated from WT and miR-155^−/−^ mice were treated with CBA (10 μg/mL) and IFN-γ (20 ng/mL), and the relative expression of M1genes and M2 genes were determined by Q-PCR. **(B)** The absolute amounts of secreted cytokines IL-10 and IL-12 (as representative of M2 and M1 gene products, respectively) in the supernatants of WT or miR-155^−/−^ BMDMs that had been treated with M1 condition (CBA + IFN-γ) and M2 condition (IL-4) were measured by ELISA. **(C)** The protein expression level of C/EBPβ in macrophages (CD11b^+^CD11c^−/low^) isolated from LPMCs of dextran sulfate sodium colitis mice were determined by western blotting. **(D)** miR-155^−/−^ BMDMs were transferred with C/EBPβ siRNA or control and then stimulated with CBA (10 μg/mL) and IFN-γ (20 ng/mL), and the relative expression of M1genes and M2 genes were determined by Q-PCR. **(E)** The protein expression level of SOCS1 and SHIP1 in macrophages, as described in **(C)**, was determined by western blotting. **(F)** miR-155^−/−^ BMDMs were transferred with SOCS1 and SHIP1 siRNA and treated as described in **(D)**, and the relative expressions of M1genes and M2 genes were determined by Q-PCR. \**P* \< 0.05, \*\**P* \< 0.01 vs WT control or siRNA control \[Student\'s *t*-test in **(A,B,D)**\]. \**P* \< 0.05, ns \> 0.05 vs. siRNA control (ANOVA with Bonferroni\'s posttest correction for multiple comparisons in **(F)**. Data are representative of three independent experiments (mean and SD). Ns, not significant. BMDMs, bone marrow-derived macrophage. WT, wild-type. CBA, cecal bacterial antigen.](fimmu-10-03153-g0002){#F2}

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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